Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

March 7, 2025

Study Completion Date

November 1, 2026

Conditions

Shingles

Interventions

DRUG

Shingrix

Shingrix vaccine will be given to all eligible patients at one to three year post allogeneic stem cell transplantation.

Trial Locations (1)

RECRUITING

Loyola University Medical Center, Maywood

All Listed Sponsors

lead

Loyola University

OTHER